Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus: Immunotherapy

M. Tagliamento, F. Grossi, S. Paolino, E. Rijavec, C. Genova, G. Rossi, F. Biello, A. De Maria

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)873-880
Number of pages8
JournalImmunother.
Volume11
Issue number10
DOIs
Publication statusPublished - 2019

Keywords

  • autoimmune disease
  • HCV
  • hepatitis C
  • immune checkpoint inhibitors
  • nivolumab
  • non-small cell lung cancer
  • systemic lupus erythematosus
  • viral hepatitis
  • bevacizumab
  • carboplatin
  • cisplatin
  • docetaxel
  • hepatitis B core antigen
  • hepatitis B surface antigen
  • hepatitis C antibody
  • hydroxychloroquine
  • paclitaxel
  • prednisone
  • sofosbuvir plus velpatasvir
  • vinorelbine tartrate
  • adult
  • advanced cancer
  • Article
  • cancer control
  • cancer patient
  • cancer staging
  • case report
  • chronic hepatitis C
  • clinical article
  • computer assisted tomography
  • drug efficacy
  • drug safety
  • female
  • Hepatitis C virus
  • human
  • laboratory test
  • middle aged
  • multiple cycle treatment
  • non small cell lung cancer
  • nonhuman
  • priority journal
  • virus load

Cite this